Lexeo Therapeutics, Inc. Common Stock
LXEO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $209 | $358 | $253 | $253 |
| - Cash | $35 | $121 | $77 | $136 |
| + Debt | $10 | $12 | $13 | $0 |
| Enterprise Value | $184 | $248 | $189 | $117 |
| Revenue | $0 | $0 | $1 | $2 |
| % Growth | – | -100% | -60.5% | – |
| Gross Profit | $0 | $0 | $1 | $2 |
| % Margin | – | – | 100% | 100% |
| EBITDA | -$96 | -$64 | -$58 | -$51 |
| % Margin | – | – | -8,874.8% | -3,054.3% |
| Net Income | -$98 | -$66 | -$59 | -$51 |
| % Margin | – | – | -9,063.8% | -3,055% |
| EPS Diluted | -3.09 | -2.49 | -2.4 | -2.01 |
| % Growth | -24.1% | -3.8% | -19.4% | – |
| Operating Cash Flow | -$81 | -$59 | -$55 | -$44 |
| Capital Expenditures | -$0 | -$0 | -$1 | -$0 |
| Free Cash Flow | -$82 | -$60 | -$55 | -$44 |